Literature DB >> 15620427

Immunohistochemical analysis of cholecystokinin A receptor distribution in the rat pancreas.

Haruaki Kageyama1, Tetsuro Kita, Shigeru Horie, Fumiko Takenoya, Hisayuki Funahashi, Sachi Kato, Masami Hirayama, Eun Young Lee, Junko Sakurai, Shuji Inoue, Seiji Shioda.   

Abstract

Cholecystokinin (CCK) plays a major role in the regulation of pancreatic enzyme secretion based on its binding to the CCK-A receptor (CCK-AR). While CCK-AR is known to be expressed in rat islet B cells, the localization of CCK-AR in rat pancreatic A and D cells remains poorly understood. The aim of this study was to identify the localization of CCK-AR in rat pancreatic islets by means of double immunofluorescence straining with antibodies against CCK-AR, glucagon, insulin and somatostatin and with in situ hybridization to detect its transcript. CCK-AR-like immunoreactive cells were found to overlap both with glucagon-like immunoreactive cells and insulin-like immunoreactive cells but not with somatostatin-like immunoreactive cells. An in situ hybridization study using a cRNA probe for CCK-AR revealed that CCK-AR mRNA was expressed in the center and periphery of the pancreatic islets. Further to this, immunofluorecsence staining using anti-glucagon antibody was carried out after in situ hybridization using the CCK-AR cRNA probe in order to identify CCK-AR mRNA expressing cells. CCK-AR mRNA exhibited a distribution pattern almost identical to that of glucagon-like immunoreactive cells. These results show clearly that CCK-AR exists not only in B but also in A cells of the rat pancreas, suggesting that CCK regulates the secretion of insulin and glucagon at least partly via CCK-AR.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15620427     DOI: 10.1016/j.regpep.2004.08.033

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  5 in total

1.  Cholecystokinin is up-regulated in obese mouse islets and expands beta-cell mass by increasing beta-cell survival.

Authors:  Jeremy A Lavine; Philipp W Raess; Donald S Stapleton; Mary E Rabaglia; Joshua I Suhonen; Kathryn L Schueler; James E Koltes; John A Dawson; Brian S Yandell; Linda C Samuelson; Margery C Beinfeld; Dawn Belt Davis; Marc K Hellerstein; Mark P Keller; Alan D Attie
Journal:  Endocrinology       Date:  2010-06-09       Impact factor: 4.736

2.  Cholecystokinin expression in the β-cell leads to increased β-cell area in aged mice and protects from streptozotocin-induced diabetes and apoptosis.

Authors:  Jeremy A Lavine; Carly R Kibbe; Mieke Baan; Sirinart Sirinvaravong; Heidi M Umhoefer; Kimberly A Engler; Louise M Meske; Kaitlyn A Sacotte; Daniel P Erhardt; Dawn Belt Davis
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-09-22       Impact factor: 4.310

3.  Expression of cholecystokinin-1 receptor is correlated with proteinuria in human diabetic nephropathy.

Authors:  Mingao Wang; Rujuan Xie; Ruichan Liu; Xibei Jia; Yushi Bao; Xiaomin Liu
Journal:  Endocrine       Date:  2012-03-07       Impact factor: 3.633

4.  Cellular and subcellular localization of cholecystokinin (CCK)-1 receptors in the pancreas, gallbladder, and stomach of mice.

Authors:  Kohtarou Konno; Hiromi Takahashi-Iwanaga; Motokazu Uchigashima; Kyoko Miyasaka; Akihiro Funakoshi; Masahiko Watanabe; Toshihiko Iwanaga
Journal:  Histochem Cell Biol       Date:  2014-09-24       Impact factor: 4.304

5.  Interleukin-6 regulates pancreatic alpha-cell mass expansion.

Authors:  Helga Ellingsgaard; Jan A Ehses; Eva B Hammar; Leentje Van Lommel; Roel Quintens; Geert Martens; Julie Kerr-Conte; Francois Pattou; Thierry Berney; Daniel Pipeleers; Philippe A Halban; Frans C Schuit; Marc Y Donath
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-21       Impact factor: 11.205

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.